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Edited by Masayuki MiyasakaAbstract In the present study, the zebraﬁsh epo cDNA was
cloned. The encoded protein displays 90%, 55% and 32% identity
to the Epo from carp, fugu and human, respectively. Through RT-
PCR, the expression of zepo mRNA was mainly in the heart and
liver. In the COS-1 cell transfection experiments, the recombinant
zEpo-HA protein was eﬃciently secreted into the culture medium
as a glycoprotein and the carbohydrate moiety can be cleaved by
the treatment of peptide-N-glycosidase F (PNGase F). Using the
morpholino approach, we showed that zepo morphants displayed
severe anemia leading to high mortality during development. Such
an eﬀect can be signiﬁcantly rescued by zepo RNA. Furthermore,
in the absence of functional zEpo, the expression of speciﬁc mark-
ers for adult globin genes, such as aA1- and bA1-globin, but not
the embryonic be1-globin, was aﬀected.
 2007 Federation of European Biochemical Societies. Published
by Elsevier B.V. All rights reserved.
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Erythropoietin (Epo) is a glycoprotein hormone with the
function as a principal regulator of erythropoiesis. In mam-
mals, the initial production organ is liver and is shifted to the
kidney after birth [1]. Eﬀects of Epo are mediated by binding
to Epo receptor (Epor), which is primarily expressed in hema-
topoietic progenitor cells [2]. Upon binding of Epo to its recep-
tor, dimerization of Epor leads to the activation of the JAK/
STAT signaling pathway [3]. The main function of Epo is to
inhibit the apoptosis of erythroid precursor cells and to increase
their survival. Currently, recombinant human Epo (rhEpo) has
been used to treat anemia caused by chronic kidney disease [4].
Moreover, rhEpo is also used to treat cancer patients with ane-
mia induced by chemotherapy or radiotherapy [5].
The ﬁrst erythropoietin gene from non-mammalian verte-
brate has been cloned from fugu and the encoded protein
shows only 32% identity to human Epo [6]. Human Epo is a
glycoprotein and contains three N-linked sugar chains on*Corresponding author. Address: Institute of Biological Chemistry,
Academia Sinica, 128, Sec 2, Academia Road, Taipei 115, Taiwan.
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doi:10.1016/j.febslet.2007.07.073Asn24, Asn38 and Asn83 as well as one O-linked sugar on
Ser126 [7]. The fugu Epo has no N-linked glycosylation site,
but it is postulated to have an O-linked glycosylation site on
Ser117 [6]. Site-directed mutagenesis analysis has indicated
that the rhEpo variant with either a double mutation
(Gln38,83) or a triple mutation (Gln24,38,83) on the three
N-glycosylation sites by replacing the asparagines (Asn) with
glutamines (Gln) was secreted poorly from COS-1 and CHO
cells [8]. The secretion ability of the fugu Epo in cultured cells
has not been determined yet.
In this study, we isolated a gene encoding zebraﬁsh Epo
(zEpo) that shows 55% and 32% identity to the Epo from fugu
and human, respectively. Unlike the fugu Epo, zEpo contains
two N-glycosylation sites and it was eﬃciently secreted into the
culture medium as a glycoprotein. Through RT-PCR, the
expression of zepo mRNA was mainly in the heart and liver.
Using morpholino approach, we showed that zEpo morphants
displayed severe anemia leading to high mortality during
development. Furthermore, in the absence of functional zEpo,
the expression of erythroid speciﬁc markers, such as adult glo-
bin genes and the embryonic be1-globin gene were examined.2. Materials and methods
2.1. Fish
Zebraﬁsh were raised and maintained under standard conditions.
Embryos were incubated at 28 C and the diﬀerent developmental
stages were determined according to the descriptions in the Zebraﬁsh
Book [9].
2.2. Total RNA isolation and RT-PCR analysis of zebraﬁsh
erythropoietin mRNA
Total RNA was isolated from the fertilized eggs at diﬀerent stages
and various tissues of zebraﬁsh (Danio rerio), using the RNAzol
reagent (Tel-Test, Friendswood, TX, USA) according to the instruc-
tions of the manufacturer. After treatment with RQ1 RNase-Free
DNaseI (Promega), 50–100 lg of total RNA was subjected to the ﬁrst
strand cDNA synthesis. PCR ampliﬁcations were performed with zepo
primers (zEPO-RT-F, 5 0-GTG CCT CTC ACT GAG TTC TTG GAA
G-3 0 and zEPO-RT-R, 5 0-CTC GTT CAG CAT GTG TAA GCC
TGA C-3 0) or b-actin primers (zAct-F, 5 0-CCT CCG GTC GTA
CCA CTG GTA T-3 0 and zAct-R, 5 0-CAA CGG AAG GTC TCA
TTG CCG ATC GTG-3 0) and the cDNA as a template.
2.3. Cloning of the full-length cDNAs encoding zEpo and hEpo
The full-length cDNA encoding zEpo was isolated by PCR ampliﬁ-
cation using gene-speciﬁc primers (zEPO-F, 5 0-ATG TTT CAC GGT
TCA GGA CTC-3 0; zEPO-R, 5 0-GCT GAC ACC CTG TCG ACAblished by Elsevier B.V. All rights reserved.
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EF426727. The full-length cDNA encoding hEpo was isolated by
PCR ampliﬁcation using gene-speciﬁc primers (hEPO-F, 5 0-ATG
GGG GTG CAC GAA TGT CCT GCC-3 0; hEPO-R, 5 0-TCT GTC
CCC TGT CCT GCA GGC CTC-3 0) according to the sequence with
GenBank accession number NM000799 from human kidney tissue
cDNA. The cDNA encoding zEpo or hEpo was subcloned into the
BamHI and EcoRI site of pHA-YUN vector [10] to generate
pCMV-zEpo-HA or pCMV-hEpo-HA, respectively. The plasmid
pCMV-GFP-HA [10] was constructed by inserting the green ﬂuores-
cence protein (GFP) coding region into pHA-YUN.
2.4. Cell cultures
Monkey kidney ﬁbroblast COS-1 cells were cultured in high-glucose
Dulbecco’s modiﬁed Eagle’s medium, supplemented with 10% fetal
bovine serum (HyClone, UT, USA) in a humidiﬁed atmosphere of
5% CO2 at 37 C. Cell transfection was carried out using Lipofect-
amine Plus reagent (Life Technologies) according to the manufac-
turer’s protocol. After transfection for 12 h, cells were incubated in
serum-free medium for an additional 36 h. Conditioned media were
then collected and concentrated with YM-10 MW Centricon (Milli-
pore, Bedford, MA). The concentrated supernatant was digested with
1 U of peptide N-glycosidase F (PNGase F) (Roche) at 37 C for 18 h.
Untreated and N-glycosidase-treated culture supernatants were ana-
lyzed by SDS–PAGE followed by detection with Western blotting.
2.5. Western blot and immunocytochemistry assay
Cells were harvested at 48 h post-transfection for Western blot and
at 24 h post-transfection for immunocytochemistry analysis. Western
blot analyses were performed with anti-HA monoclonal antibody
(1:3000; Santa Cruz, CA) at 4 C overnight. The signals were detected
using enhanced chemiluminescence (ECL) (NEN Life Science Prod-
ucts, MA). For immunocytochemistry analysis, cells were ﬁxed with
4% paraformaldehyde and permeabilized in 0.1% Triton X-100. Immu-
nostaining was performed using anti-HA antibody (1:1000) at 4 C
overnight, followed by Cy3-conjugated goat anti-mouse antibody
and co-stained with DAPI for 30 min at room temperature. Photo-
images were prepared by using a laser scanning confocal microscope
(LSM 510 Meta, Carl Zeiss Inc., Germany).
2.6. Morpholino injection
Antisense morpholinos (MOs) were synthesized by Gene Tools
(Philomath, OR, USA). The sequence of zepo-MO was as follows:
5 0-TGA AAC ATT CGC AAA ACA ACT TGG C-3 0. The MO was
dissolved in 1 · Danieau solution containing 0.5% phenol red to
0.3 mM and 3.2 ng per embryo was injected into embryos at the 1–2
cell stage. The embryos were processed for whole-mount in situ hybrid-
ization at 24 hpf or o-dianisidine staining at 48 hpf.
2.7. Morpholino rescue experiment by mRNA injection
Capped zepo sense RNA was synthesized with the mMESSAGE
mMACHINE T7 Ultra kit (Ambion, Austin, USA) according to the
manufacturer’s protocol from linearized pT7TS plasmids containing
the entire coding region of zepo cDNA. Ten picograms to 30 pg of
sense zepo RNA was co-injected with 3.2 ng zEpo-MO per embryo
at 1–2 cell stage.
2.8. o-Dianisidine staining
MO-injected or uninjected embryos at 48 hpf were dechorionated
and ﬁxed with 4% paraformaldehyde overnight. Fixed embryos were
washed in PBS for three times and then incubated in the staining buﬀer
(0.6 mg/mL o-dianisidine, 10 mM sodium acetate (pH 5.2), 0.65%
hydrogen peroxide, and 40% ethanol) for 15 min in the dark.
2.9. Whole-mount in situ hybridization
Digoxigenin-labeled antisense RNA probes were generated by
in vitro transcription using linearized plasmids as template. Whole-
mount in situ hybridization were performed as previously described
[10]. Speciﬁc primers for epo (5 0-GTG CCT CTC ACT GAG TTC
TTG GAA G-3 0 and 5 0-CTC GTT CAG CAT GTG TAA GCC
TGA C-3 0), gata1 (5 0-ACC TGA GGC TCG TGA ATG TG-3 0 and
5 0-GCT CAT CTG GAG GTG CCA TGT-3 0), scl (5 0-TCC TAG
CAA TCG AGT CAA GCG-30 and 5 0-TGG ACT CCA CTG ATGAGT CCT G-3 0), be1-globin (5 0-ACA TGG TTG TGT GGA CAG
ACT TCG AG-30 and 5 0-TTA GTG GTA CTG TCT TCC CAG
AGC GG-3 0), aA1-globin (5 0-ACG CAG CGA TGA GTC TCT
CTG ATA C-3 0 and 5 0-GCA CAG TGT TGT TGT CAG TGA
ATA T-3 0) and bA1-globin (5 0-ACA TGG TTG AGT GGA CAG
ATG CCG-3 0 and 5 0-CAT TGG CGA TGA GAC TCT AGT GGT-
3 0) were used to amplify the DNA as template.3. Results
3.1. Cloning of the erythropoietin gene from zebraﬁsh
To identify zebraﬁsh cDNA related to Fugu epo, we used the
coding region of the Fugu epo (GenBank accession number
AY303753) to search the GenBank for related expression
sequence tag (EST) sequences by using the program tBLAST.
Two zebraﬁsh EST clones (GenBank accession numbers
DN903417 and EB886593) were found and assembled to
obtain the full-length cDNA. Their sequences have been depos-
ited in GenBank with the accession number of EF426727. To
determine the genomic structure of zebraﬁsh erythropoietin
(zepo) gene, we used this cDNA as a bait to perform an online
BLAST search of the GenBank database and matched ﬁve non-
contiguous regions in the 200556 bp zebraﬁsh BAC clone
DKEY-46E6. Subsequently, we compared the sequences be-
tween this BAC clone and the zepo cDNA. The result indicates
that the epo cDNA is contained within ﬁve putative exons and
four introns spanning approximately 13.4 kb.
The deduced protein sequences were aligned with other ﬁsh
Erythropoietins and mammalian Erythropoietins. The zEpo
shows an overall identity of 90%, 55%, 32% and 35% to Epo
from carp, Fugu, human and mouse, respectively (Fig. 1B).
In a previous report, Fugu Epo also shows 32% identity to
human Epo [6]. The signal peptide of human Epo has been
assigned [7] and the corresponding regions of zEpo were also
predicted (Fig. 1B). There are four cysteine residues in mature
human Epo that form two disulphide bridges important for the
stability and function of the mature protein [11]. These cys-
teine residues are conserved in all ﬁsh Erythropoietins
(Fig. 1B). Moreover, human Epo is a glycoprotein and con-
tains three N-linked sugar chains on Asn24, Asn38 and
Asn83 [7]. Similarly, the zEpo contains two N-linked glycosyl-
ation sites, 38NVT and 81NQT.3.2. Expression proﬁles of zepo transcript in diﬀerent
developmental stages and adult tissues in zebraﬁsh
To investigate the expression pattern of zepo transcript, zeb-
raﬁsh embryos at diﬀerent developmental stages and various
tissues from adult zebraﬁsh were collected for cDNA prepara-
tion and subjected to RT-PCR. In adult zebraﬁsh, the epo
mRNA is predominantly expressed in the heart and liver, while
low expression is observed in the brain, gill, eye, intestine and
kidney (Fig. 2A). On the contrary, the kidney is the primary
organ to synthesize Epo in adult mammals [1]. This expression
pattern is consistent with that of fugu epo mRNA, which is
predominantly expressed in heart and moderate in liver and
brain [6]. During development, the zepo transcript was
detected in all stages (Fig. 2B).
We also examined the temporal and spatial patterns of zepo
mRNA expression using whole-mount in situ hybridization. In
24, 48, 72, 96 and 120 hpf embryos (Fig. 2C), zepo mRNA was
expressed in forebrain, midbrain, hindbrain and brachial arch.
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Fig. 1. Genomic organization of the zebraﬁsh erythropoietin gene and alignment of amino acid sequences of zEpo with Epos from other species. (A)
Genomic structure of the zepo gene. Exons are indicated by the boxes numbered from 1 to 5, including the coding regions (solid boxes) and the
untranslated regions (open boxes). Introns and the 5 0-ﬂanking regions are indicated by the solid lines. (B) Multiple alignment of Epos from ﬁsh and
mammals using CLUSTAL X: The amino acid sequence of the zebraﬁsh Epo (zEpo; EF426727) was compared with those from carp (ccEpo;
DQ278877), Fugu (trEpo; AY303753), human (hEpo; NM_000799) and mouse (mEpo; NM_007942). Identical residues in three proteins are
highlighted. Signal peptide and putative N-linked glycosylation sites are underlined or overlined. The conserved four cysteine residues are indicated
by arrows.
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hpf.
3.3. Secretion of zebraﬁsh Epo in COS-1 cells
Epo is a secreted glycoprotein and the signal peptide of
human Epo has been assigned [7]. The putative signal peptide
of zEpo contains 23 amino acid residues and those of human
and mouse Epo have 27 amino acid residues. Interestingly,
eight amino acids of the N-terminal 12 amino acids, AP-
PRLICDSRVL, of mature human Epo are highly conserved
between ﬁsh and mammalian Erythropoietins.
In order to conﬁrm the secretion ability of zEpo, a HA-tag
was added to the C-terminal end of zEpo. At 48 h post-trans-
fection of pCMV-zEpo-HA into COS-1 cells, the fusion pro-
tein in cell lysate or conditioned medium was detected by
SDS–PAGE and Western blot analysis using a monoclonal
antibody against HA-tag. As shown in Fig. 3A, the zEpo-HA was present in both conditioned medium and cell lysate.
The molecular mass of secreted zEpo-HA was reduced when
it was treated with PNGase F, suggesting that this fusion pro-
tein undergoes post-translational modiﬁcation of glycosyla-
tion. As a positive control, the HA-tagged human Epo was
also expressed in both conditioned medium and cell lysate
and was glycosylated in COS-1 cells.
Due to the properties of secretion and glycosylation, zEpo-
HA and hEpo-HA are expected to be localized in the ER/Gol-
gi. Immunoﬂuorescence studies of COS-1 cells transfected with
pCMV-zEpo-HA using the anti-HA monoclonal antibody re-
vealed that zEpo-HA was localized in the perinuclear region
and displayed a punctate, non-uniform expression pattern,
suggesting that it is localized to ER/Golgi (Fig. 3B). Similarly,
hEpo-HA was localized to ER/Golgi of COS-1 cells as well.
As a control, GFP-HA was localized to the cytosol with a uni-
form distribution.
Fig. 2. Expression proﬁles of zepo mRNA by RT-PCR and by whole-mount in situ hybridization. RT-PCR of zepo transcript was performed with a
pair of primers producing a DNA fragment of 438 bp. b-actin bands were used to normalize the amount of cDNA prepared from diﬀerent tissues (A)
and from embryos at diﬀerent developmental stages (B). Whole-mount in situ hybridization with antisense zepo at diﬀerent developmental stages was
performed (C). The images were taken from a lateral view, with anterior to the left and dorsal to the top. fb, forebrain; mb, midbrain; hb, hindbrain;
ba, brachial arch.
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hemoglobin production in zebraﬁsh embryos and reduction
of erythroid-speciﬁc gene expression
Morpholino (MO)-mediated knockdown of genes in zebra-
ﬁsh embryos has become a routine and eﬃcient method to pro-
vide information about gene function in vivo [12]. To examine
the function of zEpo in the regulation of hemoglobin produc-
tion, we injected zepo-MO into zebraﬁsh embryos at 1–2 cells
stage. In Fig. 4A, the presence of hemoglobin in zebraﬁsh em-
bryos was detected by o-dianisidine staining [13]. Embryos in-
jected with zepo-MO at 48 hpf displayed signiﬁcant loss of
hemoglobin (panels b and b 0), as compared to that of wild-type
embryos (panels a and a 0). Moreover, the mortality rate of
zepo-MO-injected embryos was very high (80% mortality,
n = 250), possibly due to the signiﬁcant loss of hemoglobin
and other Epo-responsive eﬀect during development [14]. In
addition, obvious pericardial edema was observed in the
EPO-MO-injected embryos. To test whether zepo RNA can
rescue this defect, we co-injected zepo-MO and zepo RNA into
zebraﬁsh embryos at the one-cell stage. Our results showed
that the mortality rate was reduced to approximately 30%
(n = 150) and zepo RNA-injected embryos displayed obvious
hemoglobins stained by o-dianisidine (panels c and c 0).
To further examine the role of Epo during primitive erythro-
genesis, we analyzed the eﬀect of zepo-MO injection on the
expression of erythroid-speciﬁc genes, such as aA1-globin,
bA1-globin, be1-globin, scl and gata1 by whole-mount in situ
hybridization. There are ﬁve adult globin genes in zebraﬁsh,
three a-globin, and two b-globin genes [15], while only one
embryonic globin gene has been identiﬁed, a b-like globin gene
(be1) [16]. In addition, the stem cell marker scl [17] and the
immature erythroblast marker gata1 [13] were also examined.As shown in Fig. 4B, there was no diﬀerence in the expression
of scl, gata1 and be1-globin in both zepo-MO-injected and
wild-type embryos at 24 hpf. However, the expression of
aA1-globin and bA1-globin was reduced signiﬁcantly in zepo-
MO-injected embryos at 24 hpf.4. Discussion
In this study, the zepo gene and its cDNA were cloned and
characterized. The cDNA encodes a protein of 183 amino
acids, which displays 55% and 32% identity to the fugu Epo
and human Epo. RT-PCR analyses showed that zepo mRNA
was primarily expressed in the heart and liver. Unlike the fugu
Epo, zEpo contains two glycosylation sites and the recombi-
nant zEpo was eﬃciently secreted into the culture medium as
a glycoprotein. Knockdown of zEpo caused severe anemia
leading to high mortality in zebraﬁsh embryos and the expres-
sions of speciﬁc markers for adult globin genes, such as aA1-
globin and bA1-globin, were aﬀected.
The genomic structure of epo genes from human and fugu
have been determined [6]. In this study, the zebraﬁsh epo gene
consists of ﬁve exons and four introns spanning approximately
13.4 kb (Fig. 1). For comparison, the human epo gene spans
only about 2.9 kb, while the fugu epo gene spans about
5.9 kb. The ﬁrst intron of fugu and zebraﬁsh epo gene is
3,105 bp and 5896 bp in length respectively, which is larger
than that of human epo gene for only 584 bp in length. The
second and the last introns of zEPO gene are also large, which
are 2052 bp and 4735 bp in length, compared to those of
human EPO gene with the length of 258 bp and 134 bp, respec-
tively. Taken together, EPO genes from zebraﬁsh, fugu and
Fig. 3. Expression and cellular localization of zEpo protein in COS-1 cells. COS-1 cells were transfected with pCMV-zEpo-HA, pCMV-hEpo-HA or
pCMV-GFP-HA as a control. (A) At 48 h post-transfection, the cell lysates (lanes 1–4) and the conditioned media (lanes 5–10) were collected for
Western blot analysis. Untreated (lane 5 or 7) and N-glycosidase-treated (lane 6 or 8) culture supernatants displayed diﬀerent electrophoretic
mobility. (B) For immunoﬂuorescence studies, transfected cells were immunostained with anti-HA antibody and Cy-3 conjugated anti-mouse
antibody. The cell nuclei were stained with DAPI (blue). Bars, 10 lm.
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introns are diﬀerent.
The predicted amino acid sequence of zEpo exhibits an over-
all identity of 90%, 55% and 32% to the Epo from carp, fugu
and human, which is consistent with the early report that fugu
Epo shows 32% identity to human Epo [6]. The possible expla-
nation for the higher identity of zEpo to carp Epo than to fugu
Epo may be due to that carp and zebraﬁsh belong to the same
family of Cyprinidae, while fugu belongs to the family of Tet-
raodontidae. In the mammalian Epo family, they appear to be
divergent, with the identity of human Epo to Epo from other
mammals ranging from 80% to 91% [18]. The human Epo
has four cysteine residues at positions 7, 29, 33 and 161 and
these residues are conserved in all ﬁsh Epos (Fig. 1B). These
residues form internal disulﬁde bonds that are essential for
the biological activity of the recombinant human Epo
[19,20]. Interestingly, the mouse Epo has proline at position
33, but has another cysteine at position 139 (Fig. 1B).Human Epo is a glycoprotein and contains three N-linked
sugar chains on Asn24, Asn38 and Asn83 as well as one O-
linked sugar on Ser126 [7]. In the putative mature form of
zEpo, two N-linked glycosylation sites, 38NVT and 81NQT,
are found (Fig. 1B), while the fugu Epo has no N-linked glycos-
ylation site [6]. In the COS-1 cell transfection experiment, the
recombinant zEpo-HA protein was eﬃciently secreted into
the culture medium as a glycoprotein and its sugar chains
can be removed by the treatment of peptide-N-glycosidase F
(PNGase F). The PNGase-treated zEpo appears to be slightly
larger than the cytosolic zEpo (Fig. 3), suggesting that the sec-
retary zEpo may contain the O-linked sugar chain. Human
Epo has an O-linked sugar on Ser126 with the ﬂanking se-
quences of TPPDAAS126AA. The fugu Epo has no N-linked
glycosylation site, but it contains an O-linked glycosylation site
on Ser117 with the ﬂanking sequences of TPPAS117AA, which
are homologous to those of human Epo [6] (Fig. 1B). On the
other hand, the O-linked glycosylation site of zEpo is localized
Fig. 4. Reduction of hemoglobin production and low expression of erythroid-speciﬁc genes in the zepo-MO-injected embryos. (A) o-dianisidine
staining of wild-type (a, a 0) or MO-injected (b, b 0) embryos were performed at 48 hpf. The presence of hemoglobin (arrow) was signiﬁcantly reduced
in MO-injected embryos. However, the loss of hemoglobin in MO-injected embryos could be rescued by the injection of zepo RNA (c, c 0). (B) Whole-
mount in situ hybridizations with antisense gata1, scl, be1-globin (bE1), aA1-globin (aA1) and bA1-globin (bA1) were performed. The images were
taken from a lateral view, with anterior to the left and dorsal to the top. Embryos were stained under the same condition and for the same period of
time to provide comparable sensitivity.
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Epo variant with either a double mutation (Gln38,83) or a tri-
ple mutation (Gln24,38,83) on the three N-glycosylation sites
by replacing the asparagines with glutamines was secreted
poorly from COS-1 and CHO cells [8]. Thus, whether the fuguEpo can be secreted eﬃciently in COS-1 cells or not needs fur-
ther investigation.
Embryonic lethality has been observed in null mutations of
the Epo gene or Epor gene in mice due to severe anemia and
tissue hypoxia [21,14]. This phenotype is consistent with our
C.-Y. Chu et al. / FEBS Letters 581 (2007) 4265–4271 4271results that zebraﬁsh embryos injected with zepo-MO dis-
played signiﬁcant loss of hemoglobin as well as high mortality
rate (Fig. 4). In the null mutations of the JAK2 gene, an impor-
tant tyrosine kinase in the Epo/Epor signal pathway, there is
fewer primitive erythrocytes and no progression of deﬁnitive
erythrocytes. Hemoglobinization of deﬁnitive erythroid cells
is almost abolished in JAK2/ fetal liver cells [22] but the
expression of embryonic globins speciﬁc for the primitive
erythrocytes appears less aﬀected [23]. Similarly, in zepo-MO-
injected zebraﬁsh embryos, only the expression of adult globin
genes, aA1-globin and bA1-globin was reduced signiﬁcantly,
while there was no change in the expression of embryonic glo-
bin gene, be1-globin (Fig. 4).
Although the fugu epo gene was the ﬁrst gene identiﬁed from
non-mammalian vertebrate [6], the function and secretion abil-
ity of the fugu Epo has not been determined yet. In the present
study, we isolated an epo gene from zebraﬁsh and demon-
strated that it is required for erythropoiesis using morpholino
approach. Moreover, the recombinant zebraﬁsh Epo protein
can be eﬃciently secreted into the culture medium as a glyco-
protein. Thus, this is the ﬁrst ﬁsh Epo that has been expressed
and extensively characterized.
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